N4 Pharma: Turner Pope
(“N4P”) has raised £1.75m (gross) new funding through an equity placing and subscription (‘the Fundraising Shares’) priced at 0.40p/share (representing a 5.9% discount to Monday’s close). Each placing and subscription share will have one warrant attached, exercisable at 0.8p for a period of three years from the second admission date. 142.78m of the Fundraise Shares have been issued utilising the Group’s existing authorities, while 294.72m shares will be issued subject to shareholder approval at a General Meeting to be held in the coming weeks, as will be the issuance and exercise of all warrants.
Disclaimer & Declaration of Interest
The information, investment views and recommendations in this article are provided for general information purposes only. Nothing in this article should be construed as a solicitation to buy or sell any financial product relating to any companies under discussion or to engage in or refrain from doing so or engaging in any other transaction. Any opinions or comments are made to the best of the knowledge and belief of the writer but no responsibility is accepted for actions based on such opinions or comments. Vox Markets may receive payment from companies mentioned for enhanced profiling or publication presence. The writer may or may not hold investments in the companies under discussion.